SCHEMBL30183142

SCHEMBL30183142

CC1(C)Cc2cnc(N)nc2-c2[nH]nc(C(=O)Nc3ccc(C(=O)N[C@H]4CC[C@H](O)CC4)cc3)c21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATR Q13535 7/20 0.44
CHEK1 O14757 4/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
TTK P33981 1/20 0.37
EIF2AK3 Q9NZJ5 1/20 0.37
SGK1 O00141 1/20 0.36
AURKA O14965 1/20 0.36
CSNK2A2 P19784 1/20 0.36
AKT1 P31749 1/20 0.36
AKT2 P31751 1/20 0.36
CSNK2B P67870 1/20 0.36
CSNK2A1 P68400 1/20 0.36
AKT3 Q9Y243 1/20 0.36
TYRO3 Q06418 1/20 0.36
PTK2 Q05397 1/20 0.36
BMPR1B O00238 2/20 0.35
BMPR1A P36894 2/20 0.35
ACVRL1 P37023 2/20 0.35
ACVR1 Q04771 2/20 0.35
TGFBR1 P36897 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20649198 1.00 ATR (0.44) ATRCHEK1SMN1; SMN2TTKEIF2AK3
SCHEMBL20649055 0.97 ATR (0.43) ATRSMN1; SMN2TTKEIF2AK3AXL
SCHEMBL30183118 0.97 ATR (0.43) ATRSMN1; SMN2TTKEIF2AK3AXL
SCHEMBL20649010 0.94 ATR (0.40) ATRSMN1; SMN2TTKEIF2AK3AURKA
SCHEMBL30183571 0.94 ATR (0.40) ATRSMN1; SMN2TTKEIF2AK3AURKA
SCHEMBL20649357 0.94 ATR (0.40) ATRSMN1; SMN2TTKEIF2AK3KDR
SCHEMBL30183165 0.94 ATR (0.40) ATRSMN1; SMN2TTKEIF2AK3KDR
SCHEMBL30183431 0.93 KIT (0.41) ATRSMN1; SMN2TTKEIF2AK3KDR
SCHEMBL20649043 0.93 KIT (0.41) ATRSMN1; SMN2TTKEIF2AK3KDR
SCHEMBL20649077 0.91 ATR (0.49) ATRTTKEIF2AK3AURKAKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110997678-B Pyrazoloquinazoline derivatives as choline kinase inhibitors 内尔维亚诺医疗科学公司 2023-02-21 CN claimed
CN-110997678-B Pyrazoloquinazoline derivatives as choline kinase inhibitors 内尔维亚诺医疗科学公司 2023-02-21 CN disclosed